STOCK TITAN

[Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Insider transaction summary: A director of Eastman Chemical Co. (EMN) recorded a non‑cash acquisition of 487 phantom stock units on 10/07/2025. The units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of annual retainer fees that would otherwise have been paid in cash. Phantom units track the market value of one share and are payable in cash after the director's service ends. Following the transaction the reporting person beneficially owns 13,391 common‑stock‑equivalent units, which includes 268 units credited since 05/01/2025 for reinvested dividend equivalents.

Riassunto delle operazioni interne: un amministratore di Eastman Chemical Co. (EMN) ha registrato un'acquisizione non monetaria di 487 unità azionarie fantasma il 10/07/2025. Le unità sono state accreditate ai sensi del Directors' Deferred Compensation Plan come deflusso automatico di una parte dei compensi annuali che altrimenti sarebbero stati pagati in contanti. Le unità fantasma seguono il valore di mercato di una azione e sono corrisposte in contanti dopo la cessazione del mandato del direttore. A seguito della transazione la persona che riporta la notifica detiene vantaggiosamente 13,391 unità equivalenti a azioni comuni, tra cui 268 unità accreditate dal 05/01/2025 per la reinvestitura degli equivalenti di dividendi.

Resumen de la transacción interna: un director de Eastman Chemical Co. (EMN) registró una adquisición no en efectivo de 487 unidades fantasma en fecha 10/07/2025. Las unidades se acreditaron bajo el Directors' Deferred Compensation Plan como una defusión automática de una parte de las tarifas anuales de retención que, de otro modo, se hubieran pagado en efectivo. Las unidades fantasma siguen el valor de mercado de una acción y se pagan en efectivo después de que termina el mandato del director. Tras la transacción, la persona que informa posee de manera beneficiosa 13,391 unidades equivalentes a acciones comunes, que incluyen 268 unidades acreditadas desde el 05/01/2025 por reinversión de equivalentes de dividendos.

내부자 거래 요약: Eastman Chemical Co. (EMN)의 이사가 10/07/2025에 현금이 아닌 취득으로 487개의 팬텀 주식 단위를 기록했습니다. 이 단위들은 현금으로 지급되었어야 하는 연간 보수의 일부를 자동으로 이연하는 Directors' Deferred Compensation Plan에 따라 계좌에 입금되었습니다. 팬텀 단위는 한 주의 시가를 추적하며, 이사 임기가 종료된 후 현금으로 지급됩니다. 거래 이후 보고자는 13,391개의 일반 주식 등가 단위를 실질적으로 소유하게 되며, 여기에는 268 단위가 05/01/2025부터 배당금 등가 재투자로 입금되었습니다.

Résumé des transactions internes : un administrateur de Eastman Chemical Co. (EMN) a enregistré une acquisition non monétaire de 487 unités fantômes le 10/07/2025. Les unités ont été créditées dans le cadre du Directors' Deferred Compensation Plan comme un report automatique d'une partie des honoraires annuels qui auraient autrement été payés en espèces. Les unités fantômes suivent la valeur marchande d'une action et sont payables en espèces après la fin du mandat du directeur. À la suite de la transaction, la personne déclarant détient effectivement 13,391 unités équivalentes à des actions ordinaires, ce qui inclut 268 unités créditées depuis le 05/01/2025 pour la réinvestissement des dividendes equivalents.

Insider-Transaktionsübersicht: Ein Direktor von Eastman Chemical Co. (EMN) verzeichnete am 07.10.2025 eine nicht zahlungswirksame Übernahme von 487 Phantomaktien-Einheiten. Die Einheiten wurden gemäß dem Directors' Deferred Compensation Plan als automatische Aufschiebung eines Teils der jährlichen Retainer-Gebühren gutgeschrieben, die andernfalls in bar gezahlt worden wären. Phantom-Einheiten verfolgen den Marktwert einer Aktie und werden nach Beendigung der Tätigkeit des Direktors in bar ausgezahlt. Nach der Transaktion besitzt die meldende Person rechtlich gesehen 13,391 Einheiten, äquivalent zu Stammaktien, wozu 268 Einheiten gehören, die seit dem 01.05.2025 aufgrund der Wiederanlage von Dividendenequivalenten gutgeschrieben wurden.

ملخص الصفقة الداخلية: سجل مدير في Eastman Chemical Co. (EMN) استحواذاً غير نقدي لـ 487 وحدة أسهم وهمية في 10/07/2025. تم اعتماد الوحدات بموجب خطة تعويضات المؤقتة للمؤسسين كإرجاء تلقائي لجزء من الرسوم السنوية التي كان من المحتمل أن تُدفع نقداً. الوحدات الوهمية تتبع القيمة السوقية لسهم واحد وتُدفع نقداً بعد انتهاء خدمة المدير. بعد الصفقة، يمتلك الشخص المبلغ تقريره بشكل فعّال 13,391 وحدة مناظرة لأسهم عادية، والتي تشمل 268 وحدة مُعتمة منذ 05/01/2025 لإعادة استثمار مكافئ dividends.

内幕交易摘要: Eastman Chemical Co. (EMN) 的一位董事在 10/07/2025 记录了 487 单幻影股票单位的非现金取得。该单位以自动递延部分年度酬金的形式被记入董事延期补偿计划中,否则本应以现金支付。幻影单位跟踪一股的市值,董事任期结束后以现金支付。交易后,申报人实际拥有 13,391 个普通股等值单位,其中自 05/01/2025 起新增的 268 单位用于再投资股息等价物。

Positive
  • Director aligned pay with shareholder outcomes by deferring retainer fees into 487 phantom stock units
  • Dividend reinvestment added 268 units since 05/01/2025, increasing long‑term notional ownership to 13,391
Negative
  • None.

Insights

Director deferred cash compensation into 487 phantom units, modestly raising long‑term alignment with shareholders.

Phantom stock units under the Directors' Deferred Compensation Plan provide cash value tied to the company's common stock price rather than actual shares; the reported 487 units increase the director's notional exposure without immediate stock transfers.

The holding of 13,391 common‑stock equivalents, including 268 dividend‑equivalent units since 05/01/2025, suggests routine compensation deferral and dividend reinvestment. Monitor future filings for additional deferrals or exercises if cash‑settlement timing becomes material within a compensation or governance review horizon of 12–24 months.

Riassunto delle operazioni interne: un amministratore di Eastman Chemical Co. (EMN) ha registrato un'acquisizione non monetaria di 487 unità azionarie fantasma il 10/07/2025. Le unità sono state accreditate ai sensi del Directors' Deferred Compensation Plan come deflusso automatico di una parte dei compensi annuali che altrimenti sarebbero stati pagati in contanti. Le unità fantasma seguono il valore di mercato di una azione e sono corrisposte in contanti dopo la cessazione del mandato del direttore. A seguito della transazione la persona che riporta la notifica detiene vantaggiosamente 13,391 unità equivalenti a azioni comuni, tra cui 268 unità accreditate dal 05/01/2025 per la reinvestitura degli equivalenti di dividendi.

Resumen de la transacción interna: un director de Eastman Chemical Co. (EMN) registró una adquisición no en efectivo de 487 unidades fantasma en fecha 10/07/2025. Las unidades se acreditaron bajo el Directors' Deferred Compensation Plan como una defusión automática de una parte de las tarifas anuales de retención que, de otro modo, se hubieran pagado en efectivo. Las unidades fantasma siguen el valor de mercado de una acción y se pagan en efectivo después de que termina el mandato del director. Tras la transacción, la persona que informa posee de manera beneficiosa 13,391 unidades equivalentes a acciones comunes, que incluyen 268 unidades acreditadas desde el 05/01/2025 por reinversión de equivalentes de dividendos.

내부자 거래 요약: Eastman Chemical Co. (EMN)의 이사가 10/07/2025에 현금이 아닌 취득으로 487개의 팬텀 주식 단위를 기록했습니다. 이 단위들은 현금으로 지급되었어야 하는 연간 보수의 일부를 자동으로 이연하는 Directors' Deferred Compensation Plan에 따라 계좌에 입금되었습니다. 팬텀 단위는 한 주의 시가를 추적하며, 이사 임기가 종료된 후 현금으로 지급됩니다. 거래 이후 보고자는 13,391개의 일반 주식 등가 단위를 실질적으로 소유하게 되며, 여기에는 268 단위가 05/01/2025부터 배당금 등가 재투자로 입금되었습니다.

Résumé des transactions internes : un administrateur de Eastman Chemical Co. (EMN) a enregistré une acquisition non monétaire de 487 unités fantômes le 10/07/2025. Les unités ont été créditées dans le cadre du Directors' Deferred Compensation Plan comme un report automatique d'une partie des honoraires annuels qui auraient autrement été payés en espèces. Les unités fantômes suivent la valeur marchande d'une action et sont payables en espèces après la fin du mandat du directeur. À la suite de la transaction, la personne déclarant détient effectivement 13,391 unités équivalentes à des actions ordinaires, ce qui inclut 268 unités créditées depuis le 05/01/2025 pour la réinvestissement des dividendes equivalents.

Insider-Transaktionsübersicht: Ein Direktor von Eastman Chemical Co. (EMN) verzeichnete am 07.10.2025 eine nicht zahlungswirksame Übernahme von 487 Phantomaktien-Einheiten. Die Einheiten wurden gemäß dem Directors' Deferred Compensation Plan als automatische Aufschiebung eines Teils der jährlichen Retainer-Gebühren gutgeschrieben, die andernfalls in bar gezahlt worden wären. Phantom-Einheiten verfolgen den Marktwert einer Aktie und werden nach Beendigung der Tätigkeit des Direktors in bar ausgezahlt. Nach der Transaktion besitzt die meldende Person rechtlich gesehen 13,391 Einheiten, äquivalent zu Stammaktien, wozu 268 Einheiten gehören, die seit dem 01.05.2025 aufgrund der Wiederanlage von Dividendenequivalenten gutgeschrieben wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mink Kim Ann

(Last) (First) (Middle)
200 S. WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units $0(1) 10/07/2025 A 487(2) (1) (1) Common Stock 487(2) $0(2) 13,391(3) D
Explanation of Responses:
1. Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock and payable only in cash after termination of service as a director.
2. Automatic deferral of a portion of director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan, which would otherwise have been paid in cash.
3. Includes 268 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Kim Ann Mink 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for EMN report on 10/07/2025?

It reports a director acquisition of 487 phantom stock units credited under the Directors' Deferred Compensation Plan on 10/07/2025.

How many common‑stock equivalents does the reporting person own after the transaction?

The reporting person beneficially owns 13,391 common‑stock equivalents following the reported transaction.

Why were phantom stock units issued instead of actual shares?

The units were an automatic deferral of director retainer fees into the Directors' Deferred Compensation Plan, payable only in cash after termination of service.

What does the Form 4 say about dividend equivalents?

It states that 268 units were credited since 05/01/2025 as hypothetical reinvestment of dividend equivalents.

Who filed the Form 4 on behalf of the reporting person?

The form is signed by Mark D. Austin by power of attorney for the reporting person on 10/09/2025.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

7.01B
113.81M
0.78%
91.74%
2.59%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT